293 related articles for article (PubMed ID: 19900965)
1. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
Qvigstad E; Moltzau LR; Aronsen JM; Nguyen CH; Hougen K; Sjaastad I; Levy FO; Skomedal T; Osnes JB
Cardiovasc Res; 2010 Mar; 85(4):763-72. PubMed ID: 19900965
[TBL] [Abstract][Full Text] [Related]
2. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR
Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992
[TBL] [Abstract][Full Text] [Related]
3. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.
Moltzau LR; Aronsen JM; Meier S; Skogestad J; Ørstavik Ø; Lothe GB; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
J Pharmacol Exp Ther; 2014 Sep; 350(3):681-90. PubMed ID: 25022512
[TBL] [Abstract][Full Text] [Related]
4. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium.
Moltzau LR; Meier S; Aronsen JM; Afzal F; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):407-17. PubMed ID: 24424715
[TBL] [Abstract][Full Text] [Related]
6. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
7. 5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles.
Afzal F; Andressen KW; Mørk HK; Aronsen JM; Sjaastad I; Dahl CP; Skomedal T; Levy FO; Osnes JB; Qvigstad E
Br J Pharmacol; 2008 Dec; 155(7):1005-14. PubMed ID: 18846035
[TBL] [Abstract][Full Text] [Related]
8. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
[TBL] [Abstract][Full Text] [Related]
9. Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I.
Wollert KC; Yurukova S; Kilic A; Begrow F; Fiedler B; Gambaryan S; Walter U; Lohmann SM; Kuhn M
Br J Pharmacol; 2003 Dec; 140(7):1227-36. PubMed ID: 14609817
[TBL] [Abstract][Full Text] [Related]
10. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
11. cGMP-PDE3-cAMP signal pathway involved in the inhibitory effect of CNP on gastric motility in rat.
Cai YL; Sun Q; Huang X; Jiang JZ; Zhang MH; Piao LH; Jin Z; Xu WX
Regul Pept; 2013 Jan; 180():43-9. PubMed ID: 23186653
[TBL] [Abstract][Full Text] [Related]
12. Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle.
Afzal F; Qvigstad E; Aronsen JM; Moltzau LR; Sjaastad I; Skomedal T; Osnes JB; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec; 384(6):543-53. PubMed ID: 21901315
[TBL] [Abstract][Full Text] [Related]
13. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
Moalem J; Davidov T; Zhang Q; Grover GJ; Weiss HR; Scholz PM
J Surg Res; 2006 Sep; 135(1):38-44. PubMed ID: 16600302
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of β2 -adrenoceptor-mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricle.
Afzal F; Aronsen JM; Moltzau LR; Sjaastad I; Levy FO; Skomedal T; Osnes JB; Qvigstad E
Br J Pharmacol; 2011 Jan; 162(1):54-71. PubMed ID: 21133887
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
[TBL] [Abstract][Full Text] [Related]
16. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
[TBL] [Abstract][Full Text] [Related]
17. Function of cardiac beta1- and beta2-adrenoceptors of newborn piglets: role of phosphodiesterases PDE3 and PDE4.
Galindo-Tovar A; Vargas ML; Kaumann AJ
Eur J Pharmacol; 2010 Jul; 638(1-3):99-107. PubMed ID: 20406625
[TBL] [Abstract][Full Text] [Related]
18. Altered role of C-type natriuretic peptide-activated pGC-cGMP-PDE3-cAMP signaling in hyperthyroid beating rabbit atria.
Wen JF; Quan HX; Zhou GH; Cho KW
Regul Pept; 2007 Aug; 142(3):123-30. PubMed ID: 17531330
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells.
Yao J; Hiramatsu N; Zhu Y; Morioka T; Takeda M; Oite T; Kitamura M
J Am Soc Nephrol; 2005 Jan; 16(1):58-67. PubMed ID: 15537869
[TBL] [Abstract][Full Text] [Related]
20. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
